Therapeutic Potential of Mesenchymal Stromal Cells and Extracellular Vesicles in the Treatment of Radiation Lesions-A Review
- PMID: 33670501
- PMCID: PMC7922519
- DOI: 10.3390/cells10020427
Therapeutic Potential of Mesenchymal Stromal Cells and Extracellular Vesicles in the Treatment of Radiation Lesions-A Review
Abstract
Ionising radiation-induced normal tissue damage is a major concern in clinic and public health. It is the most limiting factor in radiotherapy treatment of malignant diseases. It can also cause a serious harm to populations exposed to accidental radiation exposure or nuclear warfare. With regard to the clinical use of radiation, there has been a number of modalities used in the field of radiotherapy. These includes physical modalities such modified collimators or fractionation schedules in radiotherapy. In addition, there are a number of pharmacological agents such as essential fatty acids, vasoactive drugs, enzyme inhibitors, antioxidants, and growth factors for the prevention or treatment of radiation lesions in general. However, at present, there is no standard procedure for the treatment of radiation-induced normal tissue lesions. Stem cells and their role in tissue regeneration have been known to biologists, in particular to radiobiologists, for many years. It was only recently that the potential of stem cells was studied in the treatment of radiation lesions. Stem cells, immediately after their successful isolation from a variety of animal and human tissues, demonstrated their likely application in the treatment of various diseases. This paper describes the types and origin of stem cells, their characteristics, current research, and reviews their potential in the treatment and regeneration of radiation induced normal tissue lesions. Adult stem cells, among those mesenchymal stem cells (MSCs), are the most extensively studied of stem cells. This review focuses on the effects of MSCs in the treatment of radiation lesions.
Keywords: adipose tissue derived stem cells; extracellular vesicles; mesenchymal; micro vesicles; paracrine effect; radiation; stem cell.
Conflict of interest statement
The author declares no conflict of interest.
Similar articles
-
Perspectives for Future Use of Extracellular Vesicles from Umbilical Cord- and Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells in Regenerative Therapies-Synthetic Review.Int J Mol Sci. 2020 Jan 25;21(3):799. doi: 10.3390/ijms21030799. Int J Mol Sci. 2020. PMID: 31991836 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy.Cell Transplant. 2025 Jan-Dec;34:9636897241311019. doi: 10.1177/09636897241311019. Cell Transplant. 2025. PMID: 39780320 Free PMC article. Review.
-
Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases.Cells. 2019 Dec 31;9(1):98. doi: 10.3390/cells9010098. Cells. 2019. PMID: 31906087 Free PMC article. Review.
-
Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine.Stem Cell Res Ther. 2018 Mar 9;9(1):63. doi: 10.1186/s13287-018-0791-7. Stem Cell Res Ther. 2018. PMID: 29523213 Free PMC article. Review.
-
Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases.Front Immunol. 2021 Feb 5;11:591065. doi: 10.3389/fimmu.2020.591065. eCollection 2020. Front Immunol. 2021. PMID: 33613514 Free PMC article. Review.
Cited by
-
Wharton's jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury.World J Stem Cells. 2024 Jul 26;16(7):742-759. doi: 10.4252/wjsc.v16.i7.742. World J Stem Cells. 2024. PMID: 39086560 Free PMC article. Review.
-
Stem Cells and Irradiation.Cells. 2021 Mar 30;10(4):760. doi: 10.3390/cells10040760. Cells. 2021. PMID: 33808269 Free PMC article.
-
Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial.Clin Cancer Res. 2022 Jul 1;28(13):2890-2897. doi: 10.1158/1078-0432.CCR-21-4520. Clin Cancer Res. 2022. PMID: 35486613 Free PMC article. Clinical Trial.
-
Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II).Stem Cells Transl Med. 2022 May 27;11(5):478-489. doi: 10.1093/stcltm/szac011. Stem Cells Transl Med. 2022. PMID: 35435231 Free PMC article. Clinical Trial.
-
FG-4592 protects the intestine from irradiation-induced injury by targeting the TLR4 signaling pathway.Stem Cell Res Ther. 2022 Jun 21;13(1):271. doi: 10.1186/s13287-022-02945-6. Stem Cell Res Ther. 2022. PMID: 35729656 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources